Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb;30(1):100-101.
doi: 10.5021/ad.2018.30.1.100. Epub 2017 Dec 26.

A Case of Acute Generalized Exanthematous Pustulosis after Injection of an Erythropoiesis-Stimulating Agent

Affiliations

A Case of Acute Generalized Exanthematous Pustulosis after Injection of an Erythropoiesis-Stimulating Agent

Hyun Yi Suh et al. Ann Dermatol. 2018 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. (A) Multiple miliary pustules on the neck and trunk. (B) A close-up view on the neck. (C) A close-up view on the chest.
Fig. 2
Fig. 2. Subcorneal pustule with papillary edema and mixed inflammatory infiltrate of mainly neutrophils and eosinophils (H&E; A: ×100, B: ×200).

Similar articles

Cited by

References

    1. Del Vecchio L, Locatelli F. An overview on safety issues related to erythropoiesis-stimulating agents for the treatment of anaemia in patients with chronic kidney disease. Expert Opin Drug Saf. 2016;15:1021–1030. - PubMed
    1. Halevy S. Acute generalized exanthematous pustulosis. Curr Opin Allergy Clin Immunol. 2009;9:322–328. - PubMed
    1. Schmutz JL, Barbaud A, Trechot P. Epoetin alpha-induced acute generalized exanthematous pustulosis and desensitisation. Ann Dermatol Venereol. 2010;137:761–762. - PubMed
    1. Hamdi NM, Al-Hababi FH, Eid AE. HLA class I and class II associations with ESRD in Saudi Arabian population. PLoS One. 2014;9:e111403. - PMC - PubMed
    1. Casadevall N, Rossert J. Importance of biologic follow-ons: experience with EPO. Best Pract Res Clin Haematol. 2005;18:381–387. - PubMed

LinkOut - more resources